Evidence map›Paper›PMID 37599802›Full record

ArticleClinical and experimental vaccine research2023

Immunogenic characterization of AlPO

Remees Shuhsadhe, Junise Vazhayil, Heyam Saad Ali, Hiba Orsud, Ahmed Elmontaser Omer Mergani

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental vaccine research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 66% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 4 countries.

Remees ShuhsadheAL Shifa College of Pharmacy, Perinthalmanna, India.ORCID https://orcid.org/0009-0009-1900-1226
Junise VazhayilDepartment of Pharmaceutics, AL Shifa College of Pharmacy, Perinthalmanna, India.ORCID https://orcid.org/0000-0003-4190-0120
Heyam Saad AliPharmacy College, University of Khartoum, Khartoum, Sudan.ORCID https://orcid.org/0000-0002-4441-0525
Hiba OrsudMicrobiology Department, Sanimed International Lab and Management LLC, Abu Dhabi, United Arab Emirates.ORCID https://orcid.org/0009-0008-9706-8445
Ahmed Elmontaser Omer MerganiDeparment of Microbiology, Faculty of Veterinary Medicine, University of Khartoum, Khartoum, Sudan.ORCID https://orcid.org/0000-0003-1662-2421
Dar Al-Shifa Hospital · PSUniversity of Khartoum · SDAl Khawarizmi International College · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The purpose of this study was to compare the antigenic potency and stability of tetanus and diphtheria (Td) vaccines when combined with aluminum phosphate (AlPO Materials and Methods: Results: The results revealed that the liposome-mediated Td vaccines exhibited higher immunogenicity compared to the AlPO Conclusion: This study highlights the importance of utilizing liposome adjuvants in vaccine development. The liposome-mediated Td vaccines showed enhanced immunogenicity and stability, making them a promising approach for improving vaccine efficacy. Understanding and optimizing adjuvant strategies can contribute to the development of effective vaccines against various diseases.

Indexed as

Aluminum phosphateLiposomesSingle radial immunodiffusionSodium dodecyl sulfate-polyacrylamide gel electrophoresisTetanus and diphtheria vaccine

Identifiers

PMID37599802
PMCPMC10435775
OpenAlexW4385832460

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.